Royal Bank of Canada raised its price objective for Axsome Therapeutics stock.
1 report, 1 independent
Updated Jun 11
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Royal Bank of Canada raised its price objective for Axsome Therapeutics stock.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Axsome Therapeutics
American biopharmaceutical company
Nothing else this week.
-
Royal Bank of Canada
financial institution in Canada
Related events
- Morgan Stanley, Jefferies Financial Group, and Royal Bank of Canada issued rating and price target updates on September 14, 2026.
- Royal Bank of Canada raised its stake in Nurix Therapeutics, a company based in San Francisco.
- Royal Bank of Canada and Morgan Stanley updated their price targets for Broadridge Financial Solutions.
- Royal Bank of Canada raised its price objective for Franco-Nevada on September 16, 2026.
- Royal Bank of Canada lowered its target price for Arthur J. Gallagher & Co. in a research report.